Cambridge Investment Research Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,974	Closed	-$373K	–	3256
2021 Q2	$373K	Buy	2,974 +54	+2%	+$6.77K	﹤0.01%	2294
2021 Q1	$396K	Buy	2,920 +200	+7%	+$27.1K	﹤0.01%	2071
2020 Q4	$348K	Sell	2,720 -1,018	-27%	-$130K	﹤0.01%	2029
2020 Q3	$421K	Buy	+3,738	New	+$421K	﹤0.01%	1717